ISRCTN48548553
已完成
3 期
A randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline for depressive symptoms in Parkinson’s disease.Substudy on the effectiveness of nortriptyline to delay motor progression in Parkinson’s diseasewith depressive symptoms compared to placebo.
niversity College London0 个研究点目标入组 52 人2019年2月22日
概览
- 阶段
- 3 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Depression in patients with Parkinson's disease
- 发起方
- niversity College London
- 入组人数
- 52
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
2022 Protocol article in https://doi.org/10.1186/s12883-022-02988-5 (added 27/04/2023)
研究者
入排标准
入选标准
- •Current inclusion criteria as of 27/04/2023:
- •1\. Patients with a diagnosis of idiopathic PD, based on a history and neurological exam performed by the enrolling investigator with presence of at least two of the three cardinal signs of PD: rigidity, bradykinesia, and rest tremor with no evidence of diagnostic alternatives.
- •2\. Aged 18 years old or above
- •3\. Fulfilling operationally defined subsyndromal depression (presence of two or more depressive symptoms at threshold or subthreshold levels, at least one of which had to include depressed mood or anhedonia or diagnostic (DSM\-V) criteria for a depressive disorder (i.e. major depressive disorder or persistent depressive disorder)).
- •4\. Beck Depression Inventory\-II (BDI\-II) score \=14\.
- •5\. Written informed consent provided.
- •6\. Treatment with antiparkinsonian medication is optimised or stable for at least 4 weeks before date of randomisation and there are no plans to change up to primary endpoint (8 weeks).
- •Previous inclusion criteria:
- •1\. Patients with a diagnosis of idiopathic PD, based on a history and neurological exam performed by the enrolling investigator with presence of at least two of the three cardinal signs of PD: rigidity, bradykinesia, and rest tremor with no evidence of diagnostic alternatives
- •2\. Aged 18 to 85 years
排除标准
- •Current exclusion criteria as of 27/04/2023:
- •1\. Women who are pregnant, breastfeeding or of childbearing potential without effective contraception (hormonal or barrier method of birth control; or abstinence). Periodic abstinence (e.g.calendar, ovulation, symptothermal, post\-ovulation methods) and withdrawal are not acceptable methods of contraception.
- •2\. Patients who do not have sufficient understanding of the English language to be or are not able to understand the Patient Information Sheet or the self\-completed questionnaires or patients who are unable to communicate answers to the self\-rating questionnaires.
- •3\. Patients with Montreal Cognitive Assessment (MoCA) score \<16 or without capacity to consent.
- •4\. Treatment with an antidepressant within 4 weeks of enrolment (except for a small dose of amitriptyline up to 30 mg for indications other than depression).
- •5\. Patients with known severe liver failure.
- •6\. Absolute contraindications to escitalopram or nortriptyline. These include:
- •a. Patients with known QT\-interval prolongation57 or congenital long QT syndrome.
- •b. Recent myocardial infarction (\<3 months), any degree of heart block or other cardiac arrhythmias precluding treatment with nortriptyline or escitalopram according to clinical judgement.
- •7\. Medications contraindicated on nortriptyline or escitalopram. These include:
结局指标
主要结局
未指定
相似试验
进行中（未招募）
不适用
Evaluation of the 'Strengthening Families, Strengthening Communities' parenting programmeParental mental well-being and child socio-emotional well-being.Mental and Behavioural DisordersISRCTN15194500niversity College London672
已完成
不适用
REDUCE Trial: A randomised controlled trial evaluating the efficacy of indwelling pleural catheters in persistent non-malignant symptomatic pleural effusionsTopic: Respiratory disordersSubtopic: Respiratory (all Subtopics)Disease: RespiratoryRespiratoryISRCTN66354436orth Bristol NHS Trust68
进行中（未招募）
2 期
The efficacy and mechanism of trientine in patients with hypertrophic cardiomyopathyHypertrophic cardiomyopathyCirculatory SystemISRCTN57145331Manchester University NHS Foundation Trust152
已完成
不适用
Efficacy of non-thermal gas plasma on sub-clinical wound infection (biofilm) in patients with diabetic ulcersChronic diabetic foot ulcersCirculatory SystemISRCTN17491903Adtec Europe Limited21
已完成
不适用
Antiageing and anti-cellulite efficacy of a food supplementFine lines/light wrinkles, dull skin and uneven skin tone and mild to moderate cellulite-derived skin imperfectionsSkin and Connective Tissue DiseasesISRCTN36901382ROELMI HPC66